Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-α therapy

被引：0
|
作者：
Kaur, PP [1 ]
Derk, CT [1 ]
Chatterji, M [1 ]
Dehoratius, RJ [1 ]
机构：
[1] Thomas Jefferson Univ, Div Rheumatol, Dept Med, Philadelphia, PA 19107 USA
来源：
JOURNAL OF RHEUMATOLOGY | 2004年 / 31卷 / 08期
关键词：
septic arthritis; Actinobacillus ureae; rheumatoid arthritis; tumor necrosis alpha inhibitors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Actinobacillus ureae, formerly known as Pasteurella ureae, is a rare human pathogen. We describe a case of septic arthritis and abscess formation caused by this unusual organism in a patient with rheumatoid arthritis, who was being treated with tumor necrosis factor-cc inhibitors.
引用
收藏
页码：1663 / 1665
页数：3
相关论文
共 50 条
  • [21] Breast Lymphoma Complicating Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis
    Pattanaik, Debendra
    Koduru, Swapna
    Azouz, Abdallah
    Patil, Sadanand
    Carbone, Laura
    [J]. CLINICAL BREAST CANCER, 2011, 11 (06) : 413 - 416
  • [22] GENDER DIFFERENCES IN RHEUMATOID ARTHRITIS: EFFECT OF ANTI-TUMOR NECROSIS FACTOR THERAPY
    Gioia, Chiara
    Spinelli, Francesca
    Priori, Roberta
    Iannuccelli, Cristina
    Lucchino, Bruno
    Vestri, Annarita
    Valesini, Guido
    DI Franco, Manuela
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1650 - 1650
  • [23] Septic Arthritis Caused by Rothia dentocariosa in a Patient with Rheumatoid Arthritis Receiving Etanercept Therapy
    Favero, Marta
    Raffeiner, Bernd
    Cecchin, Diego
    Schiavon, Franco
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (12) : 2846 - 2847
  • [24] OUTCOMES WITH TOCILIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO ANTI-TUMOR NECROSIS FACTOR-α THERAPY.
    Emery, Paul
    Keystone, Edward
    Tony, Hans-Peter
    Cantagrel, Alain
    van Vollenhoven, Ronald F.
    Sanchez-Ortiz, Adriana
    Vernon, Emma
    Roseti, Stephanie
    Kremer, Joel
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1087 - 1087
  • [25] Requirement of methotrexate in combination with anti-tumor necrosis factor-α therapy for adequate suppression of osteoclastogenesis in rheumatoid arthritis
    Matsuno, Hiroaki
    Yoshida, Kaoru
    Ochiai, Akira
    Okamoto, Masahiro
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (12) : 2326 - 2333
  • [26] Anti-tumor necrosis factor α switching in rheumatoid arthritis and juvenile chronic arthritis
    Favalli, EG
    Arreghini, M
    Arnoldi, C
    Panni, B
    Marchesoni, A
    Tosi, S
    Pontikaki, I
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 301 - 302
  • [27] Salmonella enterica Arthritis in a Patient with Rheumatoid Arthritis Receiving Anti-tumour Necrosis Factor Therapy
    Bubonja-Sonje, M.
    Rubinic, D.
    Anic, F.
    Novak, S.
    Vuckovic, D.
    Abram, M.
    [J]. WEST INDIAN MEDICAL JOURNAL, 2013, 62 (03): : 270 - 272
  • [28] Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis
    Gonzalez-Gay, MA
    De Matias, JM
    Gonzalez-Juanatey, C
    Garcia-Porrua, C
    Sanchez-Andrade, A
    Martin, J
    Llorca, J
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) : 83 - 86
  • [29] Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha
    Richez, C.
    Blanco, P.
    Gin, H.
    Schaeverbeke, T.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (05) : 607 - 607
  • [30] Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis
    Hürlimann, D
    Forster, A
    Noll, G
    Enseleit, F
    Chenevard, R
    Distler, O
    Béchir, M
    Spieker, LE
    Neidhart, M
    Michel, BA
    Gay, RE
    Lüscher, TF
    Gay, S
    Ruschitzka, F
    [J]. CIRCULATION, 2002, 106 (17) : 2184 - 2187
12345